Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT06787586 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Volunteers
Atopic Dermatitis (AD)
Atopic Eczema
Chronic Pruritus

Interventions

DRUG: ATTO-1310
DRUG: ATTO-1310 Placebo

Sponsor

Attovia Therapeutics Inc